title: Atazanavir inhibits P-glycoprotein and multidrug resistance-associated protein efflux activity.
authors.forename: Mothanje Barbara
authors.initials: MB
authors.lastname: Lucia
authors.forename: Caterina
authors.initials: C
authors.lastname: Golotta
authors.forename: Sergio
authors.initials: S
authors.lastname: Rutella
authors.forename: Elena
authors.initials: E
authors.lastname: Rastrelli
authors.forename: Andrea
authors.initials: A
authors.lastname: Savarino
authors.forename: Roberto
authors.initials: R
authors.lastname: Cauda
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000037:antagonists & inhibitors*; D000069446:Atazanavir Sulfate; D002478:Cells, Cultured; D004347:Drug Interactions; D017320:HIV Protease Inhibitors / Q000494:pharmacology*; D006412:Hematopoietic Stem Cells / Q000378:metabolism; D006801:Humans; D008214:Lymphocytes / Q000378:metabolism; D027425:ATP-Binding Cassette, Sub-Family C Proteins / Q000037:antagonists & inhibitors*; D009842:Oligopeptides / Q000494:pharmacology*; D011725:Pyridines / Q000494:pharmacology*
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000069446:Atazanavir Sulfate; D017320:HIV Protease Inhibitors; D027425:ATP-Binding Cassette, Sub-Family C Proteins; D009842:Oligopeptides; D011725:Pyridines